Drug intelligence / Profile preview

didecyldimethylammoniumchloride + prednicarbate

Development stage
Unknown
Lead developer
Hoechst
Modality
Small Molecules
Administration
Topical
01

Overview

This is a topical combination drug consisting of didecyldimethylammonium chloride (a quaternary ammonium compound with broad-spectrum antimicrobial activity) and prednicarbate (a medium-potency topical corticosteroid). Didecyldimethylammonium chloride acts as a bactericidal and fungicidal agent, disrupting microbial cell membranes. Prednicarbate reduces inflammation by inhibiting cytokine production in skin cells. The combination has been studied for the treatment of impetiginized eczema—eczema complicated by secondary bacterial infection—where it aims to address both infection and inflammation[1][4][5]. Didecyldimethylammonium chloride is also known for its use as a disinfectant in non-pharmaceutical settings, but in this context serves as an adjunctive antimicrobial agent. Prednicarbate is valued for its anti-inflammatory effects with lower risk of skin atrophy compared to other corticosteroids[9].

Other names
didecyl-dimethyl-ammonium chloride + prednicarbateBardac-22 + prednicarbate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on didecyldimethylammoniumchloride + prednicarbate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on didecyldimethylammoniumchloride + prednicarbate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call